PROTAC HPK1 Degrader-3 , CAS No.P1436403

CAS: P1436403 Cat. No.: P1436403 분자식: C₄₃H₄₂N₈O₅ 분자량: 750.84

Storage

Store at -20°C

Shipped In

Ice chest + Ice pads

개요

PROTAC PD-L1 degrader-2 (compound C3) is an orally effective PROTAC targeting HPK1 (DC50=21.26 nM). HPK1 is a negative regulator of T cell receptors, which can lead to T cell dysfunction after abnormal activation. PROTAC PD-L1 degrader-2 can inhibit SLP76 and NF-κB signaling pathways and inhibit MAPK signal transduction, and has anticancer activity and immune activation. PROTAC PD-L1 degrader-2 has a certain oral bioavailability and can be combined with PD-L1 antibody therapy to achieve a tumor growth inhibition rate of 65.58%. PROTAC PD-L1 degrader-2 is composed of E3 ligase ligand Thalidomide , PROTAC linker tert-Butyl 3-oxoazetidine-1-carboxylate , and target protein ligand HPK1-IN-51 ; the activity control of the target protein ligand can be HPK1 ligand 1.

Specifications

보관 조건

Store at -20°C

배송

Ice chest + Ice pads

이 제품은 콜드 체인 배송이 필요합니다.지상 및 기타 경제 서비스는 사용할 수 없습니다.

이름과 식별자

분자량

750.84